Ami Klein

531 total citations
29 papers, 439 citations indexed

About

Ami Klein is a scholar working on Endocrinology, Diabetes and Metabolism, Cell Biology and Molecular Biology. According to data from OpenAlex, Ami Klein has authored 29 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Cell Biology and 6 papers in Molecular Biology. Recurrent topics in Ami Klein's work include Skin and Cellular Biology Research (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Pituitary Gland Disorders and Treatments (4 papers). Ami Klein is often cited by papers focused on Skin and Cellular Biology Research (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Pituitary Gland Disorders and Treatments (4 papers). Ami Klein collaborates with scholars based in Israel, Canada and France. Ami Klein's co-authors include Ruth Zemer, Israel Nissenkorn, Shulamit Zimlichman, Amiram Fishman, Marco M. Altaras, Gloria Rashid, Jöelle Bernheim, Arié Figer, H Joshua and B. H. Novis and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and Life Sciences.

In The Last Decade

Ami Klein

29 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ami Klein Israel 13 119 104 104 73 53 29 439
Jiro Eguchi Japan 13 191 1.6× 241 2.3× 116 1.1× 60 0.8× 34 0.6× 32 548
Laron McPhaul United States 14 59 0.5× 176 1.7× 49 0.5× 53 0.7× 38 0.7× 23 435
Kazutoshi Yamana Japan 12 78 0.7× 254 2.4× 115 1.1× 247 3.4× 98 1.8× 38 543
Burghard Abendstein Austria 12 106 0.9× 313 3.0× 132 1.3× 60 0.8× 53 1.0× 20 653
Bong Ryoul Oh United States 13 79 0.7× 463 4.5× 92 0.9× 167 2.3× 35 0.7× 23 798
Hyo Pyo Lee South Korea 16 163 1.4× 275 2.6× 147 1.4× 46 0.6× 16 0.3× 44 763
Timothy Hoops United States 14 193 1.6× 214 2.1× 100 1.0× 105 1.4× 23 0.4× 35 645
M. Takashi Japan 13 252 2.1× 196 1.9× 108 1.0× 152 2.1× 9 0.2× 37 501
Ann‐Cathrin Hellström Sweden 18 137 1.2× 175 1.7× 160 1.5× 59 0.8× 31 0.6× 31 700
Haruhiko Ozaki Japan 8 261 2.2× 125 1.2× 124 1.2× 93 1.3× 29 0.5× 16 709

Countries citing papers authored by Ami Klein

Since Specialization
Citations

This map shows the geographic impact of Ami Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ami Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ami Klein more than expected).

Fields of papers citing papers by Ami Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ami Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ami Klein. The network helps show where Ami Klein may publish in the future.

Co-authorship network of co-authors of Ami Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Ami Klein. A scholar is included among the top collaborators of Ami Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ami Klein. Ami Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rashid, Gloria, et al.. (2011). Indole-3-carbinol inhibits telomerase activity and gene expression in prostate cancer cell lines.. PubMed. 31(11). 3733–7. 14 indexed citations
2.
Rashid, Gloria, et al.. (2010). The synthetic estrogen diethylstilbestrol (DES) inhibits the telomerase activity and gene expression of prostate cancer cells. The Prostate. 70(12). 1307–1312. 23 indexed citations
3.
Drucker, Liat, et al.. (2002). Cytokeratin 20 as a Biomarker of Gestational Trophoblastic Disease: Diagnostic and Prognostic Significance. Gynecologic Oncology. 87(1). 34–38. 3 indexed citations
4.
Altaras, Marco M., Ami Klein, Ruth Zemer, et al.. (2002). Detection of Tumor Circulating Cells by Cytokeratin-20 in the Blood of Patients with Granulosa Cell Tumors. Gynecologic Oncology. 86(3). 330–336. 1 indexed citations
5.
Fishman, Amiram, Ami Klein, Ruth Zemer, et al.. (2000). Detection of Micrometastasis by Cytokeratin-20 (Reverse Transcription Polymerase Chain Reaction) in Lymph Nodes of Patients with Endometrial Cancer. Gynecologic Oncology. 77(3). 399–404. 34 indexed citations
6.
Klein, Ami, Amiram Fishman, Ruth Zemer, Shulamit Zimlichman, & Marco M. Altaras. (2000). Detection of Tumor Circulating Cells by Cytokeratin 20 in the Blood of Patients with Endometrial Carcinoma. Gynecologic Oncology. 78(3). 352–355. 15 indexed citations
7.
Figer, Arié, J. Shapira, Maya Gottfried, et al.. (1999). Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon, stomach, and lung. Cancer. 86(11). 2398–2405. 3 indexed citations
8.
Zemer, Ruth, Amiram Fishman, Jöelle Bernheim, et al.. (1998). Expression of Cytokeratin-20 in Endometrial Carcinoma. Gynecologic Oncology. 70(3). 410–413. 16 indexed citations
9.
Klein, Ami, et al.. (1998). Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. Cancer. 82(2). 349–354. 67 indexed citations
10.
Shenkerman, Galina, R. Ness-Abramof, Ruth Zemer, et al.. (1997). Induction of Apoptosis by Chlorodeoxyadenosine and Dexamethasone in B-Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 28(1-2). 153–157. 7 indexed citations
11.
Klein, Ami, Ruth Zemer, Yosef Manor, et al.. (1997). Lymphoma with multi gene rearrangement on the level of immunoglobulin heavy chain, light chains, and T‐cell receptor β chain. American Journal of Hematology. 56(4). 219–223. 1 indexed citations
12.
Lishner, Michael, Ami Klein, Yosef Manor, et al.. (1995). The BCL-1, BCL-2, and BCL-3 oncogenes are involved in chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics. 85(2). 118–123. 26 indexed citations
13.
Lishner, Michael, et al.. (1994). Delta-T-lymphocytosis in a patient with thymoma. Cancer. 74(11). 2924–2929. 7 indexed citations
14.
Klein, Ami, Yosef Manor, Valery Leytin, et al.. (1994). B-cell malignancy after low grade T-cell lymphoma. Cancer. 74(1). 164–167. 5 indexed citations
15.
Klein, Ami, et al.. (1992). The effect of butylated hydroxytoluene, with and without cortisol, on stimulated lymphocytes. Life Sciences. 50(12). 883–889. 4 indexed citations
16.
Klein, Ami, et al.. (1991). Effect of anticoagulants in vitro on the viability of lymphocytes and content of free fatty acids in plasma. In Vitro Cellular & Developmental Biology - Animal. 27(4). 307–311. 3 indexed citations
17.
Klein, Ami, et al.. (1990). Cortisol catabolism by lymphocytes of patients with chronic lymphocytic leukemia. Biochemistry and Cell Biology. 68(4). 810–813. 3 indexed citations
18.
Klein, Ami, et al.. (1990). The effect of HIV-1 infection on the lipid fatty acid content in the membrane of cultured lymphocytes. AIDS. 4(9). 865–868. 25 indexed citations
19.
Shohat, Batya, et al.. (1979). T lymphocytes and plasma inhibitory factor in ACTH-dependent Cushing's patients. Clinical Immunology and Immunopathology. 13(4). 452–461. 14 indexed citations
20.
Eckstein, Benjamin & Ami Klein. (1971). Inhibition of 11β-hydroxylation of deoxycorticosterone in mitochondria of bovine adrenal cortex. Journal of Steroid Biochemistry. 2(4). 349–353. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026